Ovarian cancer with high-level focal ERBB2 amplification responds to trastuzumab and pertuzumab

Publication date: Available online 19 May 2021Source: Gynecologic Oncology ReportsAuthor(s): Laure Thouvenin, Mélinda Charrier, Sophie Clement, Yann Christinat, Jean-Christophe Tille, Mauro Frigeri, Krisztian Homicsko, Olivier Michielin, Alexandre Bodmer, Pierre O. Chappuis, Thomas A. McKee, Petros Tsantoulis

Source: Gynecologic Oncology Reports - May 19, 2021 Category: OBGYN Source Type: research